{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:30:00Z","timestamp":1768271400907,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL140934"],"award-info":[{"award-number":["R01HL140934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL142903"],"award-info":[{"award-number":["R01HL142903"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL145473"],"award-info":[{"award-number":["R01HL145473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL120826"],"award-info":[{"award-number":["T32 HL120826"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006474","name":"Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.stemcr.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T10:32:55Z","timestamp":1659609175000},"page":"2023-2036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential"],"prefix":"10.1016","volume":"17","author":[{"given":"Marissa J.","family":"Stutzman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.S. John","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Tester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha K.","family":"Hamrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Dotzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco C.","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeevan B.","family":"GC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2022.07.002_bib2","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1111\/febs.12194","article-title":"Ryanodine receptor calcium release channels: lessons from structure-function studies","volume":"280","author":"Amador","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.stemcr.2022.07.002_bib3","doi-asserted-by":"crossref","first-page":"20144","DOI":"10.1074\/jbc.M010771200","article-title":"Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor)","volume":"276","author":"Balshaw","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.stemcr.2022.07.002_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2022.07.002_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.stemcr.2022.07.002_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2018.08.011","article-title":"Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice","volume":"122","author":"Froese","year":"2018","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.stemcr.2022.07.002_bib8","doi-asserted-by":"crossref","first-page":"e0126596","DOI":"10.1371\/journal.pone.0126596","article-title":"Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells","volume":"10","author":"Fuerstenau-Sharp","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2022.07.002_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2006.08.115","article-title":"Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies","volume":"42","author":"George","year":"2007","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.stemcr.2022.07.002_bib10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.hrthm.2019.02.012","article-title":"Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors","volume":"16","author":"Giudicessi","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.stemcr.2022.07.002_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-019-1377-y","article-title":"Modulation of cardiac ryanodine receptor 2 by calmodulin","volume":"572","author":"Gong","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2022.07.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J.\u00a0Mol. Graph."},{"key":"10.1016\/j.stemcr.2022.07.002_bib13","doi-asserted-by":"crossref","first-page":"eabb2964","DOI":"10.1126\/sciadv.abb2964","article-title":"Structural mechanism of two gain-of-function cardiac and skeletal RyR mutations at an equivalent site by cryo-EM","volume":"6","author":"Iyer","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.stemcr.2022.07.002_bib15","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1073\/pnas.0600268103","article-title":"Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy","volume":"103","author":"Kannankeril","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2022.07.002_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.CIR.103.4.485","article-title":"Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia","volume":"103","author":"Laitinen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib18","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","article-title":"Calcium signaling and cardiac arrhythmias","volume":"120","author":"Landstrom","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.stemcr.2022.07.002_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.stemcr.2022.07.002_bib20","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib21","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/01.CIR.0000132472.98675.EC","article-title":"Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak","volume":"109","author":"Lehnart","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2015.09.029","article-title":"Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with beta1-selective beta-blockers in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Leren","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.stemcr.2022.07.002_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.RES.0000235869.50747.e1","article-title":"Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model","volume":"99","author":"Liu","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.stemcr.2022.07.002_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pcad.2007.10.005","article-title":"Catecholaminergic polymorphic ventricular tachycardia","volume":"51","author":"Liu","year":"2008","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.stemcr.2022.07.002_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.str.2005.06.005","article-title":"The pore structure of the closed RyR1 channel","volume":"13","author":"Ludtke","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.stemcr.2022.07.002_bib26","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib27","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.stemcr.2022.07.002_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cardiores.2006.04.004","article-title":"Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy","volume":"71","author":"Milting","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.stemcr.2022.07.002_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","article-title":"Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview","volume":"111","author":"Mummery","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.stemcr.2022.07.002_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/cvr\/cvq108","article-title":"Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure","volume":"87","author":"Ono","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.stemcr.2022.07.002_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/eurheartj\/ehl543","article-title":"Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves","volume":"28","author":"Paavola","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.stemcr.2022.07.002_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multi-center cohort study on beta-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"145","author":"Peltenburg","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib33","doi-asserted-by":"crossref","first-page":"aah5324","DOI":"10.1126\/science.aah5324","article-title":"Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.stemcr.2022.07.002_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.stemcr.2022.07.002_bib35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1242\/dmm.026823","article-title":"A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses","volume":"9","author":"Preininger","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.stemcr.2022.07.002_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nsmb938","article-title":"Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM","volume":"12","author":"Samso","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.stemcr.2022.07.002_bib40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/CIRCULATIONAHA.111.023259","article-title":"Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca(2)(+)release leading to catecholaminergic polymorphic ventricular tachycardia","volume":"124","author":"Suetomi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2022.07.002_bib41","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0735-1097(99)00461-1","article-title":"Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts","volume":"34","author":"Swan","year":"1999","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.stemcr.2022.07.002_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/cvr\/cvn303","article-title":"Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts","volume":"81","author":"Tateishi","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.stemcr.2022.07.002_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/hmg\/10.3.189","article-title":"Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)","volume":"10","author":"Tiso","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.stemcr.2022.07.002_bib44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nprot.2016.152","article-title":"Efficient, footprint-free human iPSC genome editing by consolidation of Cas9\/CRISPR and piggyBac technologies","volume":"12","author":"Wang","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stemcr.2022.07.002_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(03)00434-3","article-title":"FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death","volume":"113","author":"Wehrens","year":"2003","journal-title":"Cell"}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671122003617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671122003617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:48:14Z","timestamp":1761990494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671122003617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2213671122003617"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2022.07.002","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}